The Effect of Antenatal Corticosteroids on Fetal Growth, Survival, and Neurodevelopmental Outcome in Triplet Pregnancies

Triplet pregnancies have increased as a result of infertility therapy. The objectives of this study are to review the outcome of triplet pregnancies and to determine the effect of different antenatal corticosteroid treatments on fetal growth, survival, and neurodevelopmental outcome. A retrospective case note review of infant and maternal records from a single tertiary neonatal unit was performed from January 1, 1986, through December 31, 1999; 173 live births from 60 triplet pregnancies were divided into groups according to maternal antenatal corticosteroid exposure. Logistic regression model showed only gestation had a significant effect on survival. There was no adverse effect of steroid exposure on weight or head circumference at birth. Ninety percent of live births survived to discharge. Of 143 survivors, only five infants had documented neurodevelopmental problems. Survival rate in triplet pregnancy is high. In this analysis of cohort data repetitive antenatal steroids were not associated with adverse outcome.

Triplet pregnancies - repetitive antenatal corticosteroids - neurodevelopmental outcome

REFERENCES

• 1 Murphy M, Hey K, Brown J, Willis B, Ellis J D, Barlow D. Infertility treatment and multiple birth rates in Britain 1938-94.  J Biosoc Sci. 1997;  29 235-243
• 2 Malone F D, Chelmow D, Athanassiou A, D'Alton M E. Maternal morbidity associated with triplet pregnancy.  Am J Perinatol. 1998;  15 73-77
• 3 Royal College of Obstetricians and Gynaecologists .The management of infertility in tertiary care. London; RCOG 2000 (Evidence Based Clinical Guideline No. 6.)
• 4 Pons J, Charlemaine C, Dubreuil E, Papiernik E, Frydman R. Management and outcome of triplet pregnancy.  Eur J Obstet Gynecol Reprod Biol. 1998;  76 131-139
• 5 American College of Obstetricians and Gynaecologists .ACOG Committee Opinion No. 147: antenatal steroid therapy for fetal maturation. Int J Gynaecol Obstet. 1995 48: 340-342
• 6 Taeusch H W. Glucocorticoid prophylaxis for respiratory distress syndrome: a review of potential toxicity.  J Pediatr. 1975;  87 617-623
• 7 Turrentine M A, Wilson P D, Wilkins I A. A retrospective analysis of the effect of antenatal steroid administration on the incidence of respiratory distress syndrome in preterm twin pregnancies.  Am J Perinatol. 1996;  13 351-354
• 8 Quist-Therson E C, Myhr T L, Ohlsson A. Antenatal steroids to prevent respiratory distress syndrome: multiple gestation as an effect modifier.  Acta Obstet Gynecol Scand. 1999;  78 388-392
• 9 Liggins G C, Howie R N. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.  Pediatrics. 1972;  50 515-525
• 10 Crowley P. Prophylactic corticosteroids for preterm birth.  Cochrane Database Syst Rev. 2000;  2 CD000065
• 11 NIH Consensus Statement . Effect of corticosteroids for fetal maturation on perinatal outcomes.  JAMA. 1995;  273 413-418
• 12 Banks B A, Cnaan A, Morgan M A et al.. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North America, Thyrotropin-Releasing Hormone Study Group.  Am J Obstet Gynecol. 1999;  181 709-717
• 13 National Institutes of Health . Antenatal corticosteroids revisited: repeated courses. NIH Consensus Statement 2000.  Obstet Gynecol. 2001;  98 144-150
• 14 Kuhn R J, Speirs A L, Pepperell R J, Eggers T R, Doyle L W, Hutchison A. Betamethasone, albuterol, and threatened premature delivery: benefits and risks. Study of 469 pregnancies.  Obstet Gynecol. 1982;  60 403-408
• 15 Doyle L W, Ford G W, Rickards A L et al.. Antenatal corticosteroids and outcome at 14 years of age in children with birth weight less than 1501 grams.  Pediatrics. 2000;  106 E2
• 16 Elimian A, Verma U, Visintainer P, Tejani N. Effectiveness of multidose antenatal steroids.  Obstet Gynecol. 2000;  95 34-36
• 17 Smith L, Qureshi N, Chao C R. Effects of single and multiple courses of antenatal glucocorticoids in preterm newborns less than 30 weeks gestation.  J Matern Fetal Med. 2000;  9 131-135
• 18 Dirnberger D, Yoder B, Gordon M. Single versus repeated-course antenatal corticosteroids: outcomes in singleton and multiple-gestation pregnancies.  Am J Perinatol. 2001;  18 267-278
• 19 French N, Hagan R, Evans S, Godfrey M, Newnham J. Repeated antenatal corticosteroids: size at birth and subsequent development.  Am J Obstet Gynecol. 1999;  180 114-121
• 20 Abbasi S, Hirsch D, Davis J et al.. Effect of single versus multiple courses of antenatal corticosteroids on maternal and neonatal outcome.  Am J Obstet Gynecol. 2000;  182 1243-1249
• 21 Brocklehurst P, Gates S, Johnson A, Alfirevic Z, Chamberlain G. Effects of multiple courses of antenatal steroids are uncertain [letter].  BMJ. 2000;  321 47